These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 9467429)

  • 1. Monocyte cytokine production in an elderly population: effect of age and inflammation.
    Roubenoff R; Harris TB; Abad LW; Wilson PW; Dallal GE; Dinarello CA
    J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M20-6. PubMed ID: 9467429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients.
    Liou LB
    Clin Exp Rheumatol; 2001; 19(5):515-23. PubMed ID: 11579710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes.
    Wolf HM; Hauber I; Gulle H; Samstag A; Fischer MB; Ahmad RU; Eibl MM
    Clin Exp Immunol; 1996 Sep; 105(3):537-43. PubMed ID: 8809146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine antagonists in aged subjects and their relation with cellular immunity.
    Catania A; Airaghi L; Motta P; Manfredi MG; Annoni G; Pettenati C; Brambilla F; Lipton JM
    J Gerontol A Biol Sci Med Sci; 1997 Mar; 52(2):B93-7. PubMed ID: 9060965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes.
    Granowitz EV; Clark BD; Vannier E; Callahan MV; Dinarello CA
    Blood; 1992 May; 79(9):2356-63. PubMed ID: 1533322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of peripheral monocyte derived interleukin 1beta (IL-1beta), IL-1 receptor antagonist, and tumor necrosis factor-alpha with osteoarthritis in the elderly.
    Fraenkel L; Roubenoff R; LaValley M; McAlindon T; Chaisson C; Evans S; Harris T; Dinarello CA; Felson DT
    J Rheumatol; 1998 Sep; 25(9):1820-6. PubMed ID: 9733466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells.
    Drenth JP; Göertz J; Daha MR; van der Meer JW
    Immunology; 1996 Jul; 88(3):355-62. PubMed ID: 8774350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells.
    Gabay C; Genin B; Mentha G; Iynedjian PB; Roux-Lombard P; Guerne PA
    Clin Exp Immunol; 1995 May; 100(2):306-13. PubMed ID: 7743670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different monocyte reaction patterns in newly diagnosed, untreated rheumatoid arthritis and lupus patients probably confer disparate C-reactive protein levels.
    Liou LB
    Clin Exp Rheumatol; 2003; 21(4):437-44. PubMed ID: 12942694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis.
    Hart PH; Ahern MJ; Smith MD; Finlay-Jones JJ
    Immunology; 1995 Apr; 84(4):536-42. PubMed ID: 7790026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide from Actinobacillus actinomycetemcomitans stimulates production of interleukin-1beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-1 receptor antagonist in human whole blood.
    Schytte Blix IJ; Helgeland K; Hvattum E; Lyberg T
    J Periodontal Res; 1999 Jan; 34(1):34-40. PubMed ID: 10086884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients.
    Le Meur Y; Lorgeot V; Aldigier JC; Wijdenes J; Leroux-Robert C; Praloran V
    Nephrol Dial Transplant; 1999 Oct; 14(10):2420-6. PubMed ID: 10528667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
    Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells.
    Tilg H; Vannier E; Vachino G; Dinarello CA; Mier JW
    J Exp Med; 1993 Nov; 178(5):1629-36. PubMed ID: 7693853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine-induced interleukin-1 receptor antagonist release in mononuclear phagocytes.
    Marsh CB; Wewers MD
    Am J Respir Cell Mol Biol; 1994 May; 10(5):521-5. PubMed ID: 8179914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism.
    Danis VA; Millington M; Hyland VJ; Grennan D
    Clin Exp Immunol; 1995 Feb; 99(2):303-10. PubMed ID: 7851026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
    Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
    Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological and cytokine responses in IL-1 beta-deficient mice after zymosan-induced inflammation.
    Fantuzzi G; Sacco S; Ghezzi P; Dinarello CA
    Am J Physiol; 1997 Jul; 273(1 Pt 2):R400-6. PubMed ID: 9249578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in interleukin 1 (IL-1), IL-6, tumor necrosis factor and IL-1 receptor antagonist production by human monocytes stimulated with muramyl dipeptide (MDP) and its stearoyl derivative, romurtide.
    Suzuki K; Torii K; Hida S; Hayashi H; Hiyama Y; Oomoto Y; Takii T; Chiba T; Onozaki K
    Immunopharmacology; 1994; 28(1):31-8. PubMed ID: 7928300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1beta production but decreased tumour necrosis factor-alpha production after a 5-km run.
    Drenth JP; Krebbers RJ; Bijzet J; van der Meer JW
    Eur J Clin Invest; 1998 Oct; 28(10):866-72. PubMed ID: 9793002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.